OakChart

MEDIROM Healthcare Technologies Inc ADR

MRMConsumer Cyclical·Personal Services·Japan·Nano·NASD·Nov 11 • 3:08 PM ET

0.2750+0.0139 (5.32%)
2026-11-11 21:30 CET
Market cap
2.06 USD m
Revenue, TTM
4.04 USD m
Net income, TTM
0.37 USD m
Free cash flow, TTM
- USD m
EPS diluted, TTM
-
P/E
-
Compare

Price

MRM against its 20, 50 and 200-day averages
2050200
0.501.001.508.8M17.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MRMclose 0.2820-day 0.3350-day 0.56200-day 0.990.28

88.2% under the 52-week high of 2.33 on 11 Dec 2025. 52-week low 0.25 on 14 Oct 2026. Last 15 sessions, 45.1% high to low

Volume 0.04× normal · the line is the 50-bar volume average

Profile

MRM
52-week range, 1% of the way up
0.252.33

MEDIROM Healthcare Technologies, Inc. owns, develops, operates, manages, and supports relaxation salons through the franchising and direct ownership of such salons. It provides relaxation and bodywork services. The firm operates two synergistic lines of businesses: Relaxation Salon Segment (retail) and Digital Preventative Healthcare Segment (healthtech). The company was founded by Kouji Eguchi on July 13, 2000 and is headquartered in Tokyo, Japan.

IPODec 29, 2020
Beta1.52
ATR, 14d0.04
Rel volume0.04
Inst own2.31%

Snapshot

6 groups

Valuation

Index-
Market Cap2.17M
Enterprise Value-
Income-
Sales-
Book/sh-
Cash/sh-
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees-
IPODec 29, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B-
P/C-
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio-
Current Ratio-
Debt/Eq-
LT Debt/Eq-
Option/ShortNo / Yes

Earnings

EPS (ttm)-
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y-38.82% -
Sales past 3/5Y-57.56% -33.60%
EPS Y/Y TTM426.04%
Sales Y/Y TTM-
EPS Q/Q24.42%
Sales Q/Q-4.29%
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own-
Insider Trans-
Inst Own2.31%
Inst Trans23.46%
ROA-
ROE-
ROIC-
Gross Margin-
Oper. Margin-
Profit Margin-
SMA20-16.81%
SMA50-50.62%
SMA200-72.30%
Trades-

Technical

Shs Outstand7.90M
Shs Float-
Short Float-
Short Ratio0.07
Short Interest0.01M
52W High2.33 -88.20%
52W Low0.25 12.24%
Volatility9.90% 16.79%
ATR (14)0.04
RSI (14)23.14
Beta1.52
Rel Volume0.04
Avg Volume137.34K
Volume5,240

Performance

Perf Week-11.46%
Perf Month-16.67%
Perf Quarter-73.04%
Perf Half Y-71.36%
Perf YTD-85.82%
Perf Year-86.71%
Perf 3Y-94.36%
Perf 5Y-96.16%
Perf 10Y-
Recom1.00
Target Price5.00
Prev Close0.26
Price0.28
Change %5.32%

Peers

Mkt cap
TickerCompanyMkt cap
RGSRegis Corp59.55M
XPOFXponential Fitness Inc234.05M
OSWOneSpaWorld Holdings Limited3.17B
EJHE-Home Household Service Holdings Ltd3.71M
TRNRInteractive Strength Inc2.04M
MEDMedifast Inc146.94M
PLNTPlanet Fitness Inc4.65B
LTHLife Time Group Holdings Inc10.74B
WWWW International Inc131.44M
BODIBeachbody Company Inc26.37M

News

latest 14 of 200
  • MEDIROM MOTHER Labs Expands Deployment of "REMONY" Remote Health Monitoring System in JGSDF 8th Division (GlobeNewswire) -5.61%
  • MEDIROM Group Reports Q1 2026 Results (GlobeNewswire) -5.00%
  • Micromem Technologies Inc. Provides Update on Gas-Sensing Technology Development (TMX Newsfile)
  • Micromem Technologies Inc. Provides Update on Liquid-Sensing Technology Development (TMX Newsfile)
  • MEDIROM Launches Partnership with Tools for Humanity in February; Projects Approximately $39 Million in Income Before Income Taxes Over Two Years Following Expansion to 3,000 Nationwide Locations (GlobeNewswire) -5.25%
  • MEDIROM Forms New Special Mission Team to Drive World ID Adoption Across 3,000 Locations Through Partnership with Tools for Humanity (GlobeNewswire)
  • World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku's "Orb" Authentication Surpasses 20,000 Cumulative Verifications, Doubling in Approximately Two Months (GlobeNewswire)
  • MEDIROM Partners with World on Technology Envisioned by Sam Altman and Alex Blania: Deploying "Proof of Human" Infrastructure throughout Japan (GlobeNewswire)
  • MEDIROM Partners with World (GlobeNewswire)
  • MEDIROM Mother Labs Partners with TD SYNNEX to Accelerate National Adoption of "MOTHER Bracelet" and "REMONY" (GlobeNewswire)
  • MEDIROM MOTHER Labs Inc. Receives Capital Investment from Internal Investors (GlobeNewswire) +7.73% -7.62%
  • MEDIROM to Launch New Treasury Strategy Utilizing Cryptocurrency (GlobeNewswire) -20.99%
  • More than 10,000 people receive verified World IDs at MEDIROM locations (GlobeNewswire)
  • Series A Round Valuation: ¥9 Billion: MEDIROM MOTHER Labs Inc. Decides to Make an Investment from Internal Investors (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
No quarterly earnings.

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2024FY0.197--57.4154.70

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2025FYS2025-05-1010058.0058.0058.00
2025FYS2025-05-0910058.0058.0058.00
2025FYS2025-05-0810058.0058.0058.00
2025FYS2025-05-0710058.0058.0058.00
2025FYS2025-05-0610058.0058.0058.00
2025FYS2025-05-0510058.0058.0058.00
2025FYS2025-05-0410058.0058.0058.00
2025FYS2025-05-0310058.0058.0058.00
2025FYS2025-05-0210058.0058.0058.00
2025FYS2025-05-0110058.0058.0058.00
2025FYS2025-04-3010058.0058.0058.00
2025FYS2025-04-2910058.0058.0058.00
2025FYS2025-04-2810058.0058.0058.00
2025FYS2025-04-2710058.0058.0058.00

Estimate history

EPS, annual0.1490.04-1.255-1.8490.2070.1590.168-
Period20182019202020212022202320242025
EPS, quarterly
Period
Sales, annual31.08535.85231.29849.23752.87148.55854.7824.041
Period20182019202020212022202320242025
Sales, quarterly
Period
Shares, annual4.0234.0234.8234.8834.8834.8837.9027.902
Period20182019202020212022202320242025
Shares, quarterly
Period

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue4.044.0454.7848.5652.8749.2431.3035.8531.09
Cost of Goods Sold Incl. D&A0.140.1439.9537.4038.4136.3527.2827.1322.42
Gross Profit3.903.9014.8311.1614.4612.884.028.728.66
Selling, General and Administrative Excl. Other3.493.4914.8013.9413.7316.5910.018.007.63
Other Operating Expense--0.000.000.000.000.000.000.00
Operating Income0.410.410.03-2.780.74-3.71-5.990.721.03
Non-Operating Income (Expense)0.350.350.673.040.550.370.200.050.01
Interest Expense0.390.390.330.260.070.110.120.120.14
Unusual Expense--0.06-0.15-0.160.32-0.050.350.07
Net Income Before Taxes0.380.380.310.151.37-3.77-5.870.300.83
Income Taxes0.010.01-0.60-0.670.235.24-0.820.150.23
Other After Tax Adjustments--0.000.000.000.000.000.000.00
Consolidated Net Income0.370.370.910.821.13-9.02-5.050.160.60
Net Income From Continuing Operations0.370.370.980.821.13-9.02-5.050.160.60
Net Income0.370.370.980.821.13-9.02-5.050.160.60
EPS (Recurring)--0.170.140.19-1.80-1.260.100.16
EPS (Basic, Before Extraordinaries)0.050.050.190.170.23-1.85-1.250.040.15
EPS (Diluted)--0.170.160.21-1.85-1.250.040.15
EBITDA0.510.511.95-0.992.14-2.56-5.411.151.43
Stock Option Compensation Expense----0.00---0.00
Price To Earnings Ratio0.710.71-31.45-----
Price To Sales Ratio-3.790.110.610.470.601.85--
Gross Margin-96.5927.0722.9827.3626.1612.8424.3327.87
Operating Margin-10.250.06-5.731.39-7.53-19.142.023.32
Net Margin-9.271.791.692.14-18.31-16.140.441.93
Shares Outstanding-7.907.904.884.884.884.824.024.02
Market Capitalization2.062.065.0927.9322.0229.1969.4459.73-

Income statement, quarterly

Currency USD, millions
Metric2024S22024S12023S22023S12022S22022S12021S2
Total Revenue-31.9922.8324.5224.0327.2325.5729.33
Cost of Goods Sold Incl. D&A-20.9219.0418.4419.0019.4618.9419.89
Gross Profit-11.073.796.095.037.776.639.44
Selling, General and Administrative Excl. Other-6.827.976.647.335.987.888.78
Other Operating Expense-0.000.000.000.000.000.000.00
Operating Income-4.25-4.18-0.56-2.301.79-1.250.67
Interest Expense-0.190.140.140.120.030.050.05
Unusual Expense-0.15-0.09-0.07-0.08-0.02-0.140.33
Net Income Before Taxes-4.19-3.842.54-2.602.42-1.290.47
Income Taxes--0.620.02-0.670.030.060.184.66
Consolidated Net Income-4.82-3.873.22-2.632.36-1.48-4.19
Net Income From Continuing Operations-4.85-3.823.22-2.632.36-1.48-4.19
Net Income-4.85-3.823.22-2.632.36-1.48-4.19
EPS (Recurring)-0.98-0.790.65-0.550.48-0.32-0.81
EPS (Basic, Before Extraordinaries)-0.98-0.780.66-0.540.48-0.30-0.86
EPS (Diluted)-0.95-0.780.66-0.540.48-0.30-0.86
EBITDA-4.88-2.890.48-1.552.46-0.511.44
Non-Operating Income (Expense)-0.290.393.17-0.260.64-0.140.18
Price To Earnings Ratio--21.5531.4529.85---
Price To Sales Ratio-0.100.410.580.520.420.530.60
Gross Margin-34.6116.5924.8220.9428.5425.9232.20
Operating Margin-13.30-18.32-2.27-9.576.58-4.882.28
Net Margin-15.15-16.7513.12-10.958.68-5.77-14.29
Shares Outstanding-7.904.944.884.884.884.884.88
Market Capitalization-5.0919.5027.9326.5122.0229.7529.19

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments0.132.140.944.793.4514.265.082.23
Short Term Receivables22.4912.748.7110.047.435.427.045.71
Inventories-0.960.990.860.160.080.050.06
Other Current Assets0.141.381.832.220.970.460.510.52
Total Current Assets22.7717.2212.4717.9112.0020.2212.698.51
Net Property, Plant & Equipment0.5215.9718.0218.0419.5317.5818.3920.72
Total Investments and Advances1.500.560.580.400.460.000.130.47
Long-Term Note Receivable0.000.540.680.750.881.130.981.00
Intangible Assets0.109.739.977.158.612.411.431.28
Deferred Tax Assets0.477.227.130.016.4911.562.052.08
Other Assets1.145.666.146.898.477.658.117.15
Total Assets26.5056.8854.9951.1456.4560.5543.7841.22
Short Term Debt Incl. Current Port. of LT Debt11.0812.128.966.597.978.729.9010.77
Accounts Payable1.436.450.981.572.010.651.131.29
Income Tax Payable0.010.370.110.450.350.420.160.12
Other Current Liabilities0.507.6615.2118.9917.4315.909.639.24
Total Current Liabilities13.0226.6125.2627.6027.7625.6920.8221.43
Long Term Debt3.8013.0516.9217.9016.2916.0911.8515.19
Provision for Risks Charges0.242.412.442.362.571.851.171.09
Deferred Tax Liabilities-5.406.410.016.495.21--
Other Liabilities0.931.852.433.725.156.954.424.58
Total Liabilities17.9949.3253.4651.5958.2655.7938.2642.29
Non-Equity Reserves-0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value-1.270.000.000.000.000.000.00
Common Equity8.515.941.50-0.45-1.814.765.52-1.07
Total Shareholders Equity8.517.211.50-0.45-1.814.765.52-1.07
Accumulated Minority Interest-0.350.040.000.000.000.000.00
Total Equity8.517.561.53-0.45-1.814.765.52-1.07
Total Liabilities & Stockholders Equity26.5056.8854.9951.1456.4560.5543.7841.22
Book Value Per Share1.080.750.31-0.09-0.370.991.37-0.27
Tangible Book Value Per Share1.06-0.48-1.74-1.56-2.130.491.02-0.58
Full-Time Employees01,0511,101979480325233-
Price to Book Ratio1.23-2.25-62.06-7.67-16.3314.5941.02-
Return on Assets0.901.761.552.11-15.41-9.680.37-
Return on Equity4.7722.55156.96--611.55-98.257.15-
Return on Invested Capital3.044.854.466.49-62.29-24.220.924.25
Quick Ratio-0.610.450.620.430.780.610.39
Current Ratio1.750.650.490.650.430.790.610.40

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income--0.910.821.13-9.02-5.050.160.60
Depreciation--1.911.801.401.150.580.420.40
Deferred Taxes & Investment Tax Credit---1.25-0.720.005.02-1.000.050.17
Other Funds (Non Cash)---10.38-8.65-6.71-2.231.320.470.36
Funds from Operations---8.80-6.76-4.17-5.08-4.151.111.53
Extraordinary Item--0.000.000.000.000.000.000.00
Changes in Working Capital--0.012.27-1.040.010.71-1.04-0.25
Income Taxes Payable--0.29-0.320.15-0.030.240.040.04
Cash from Operating Activities---8.79-4.49-5.21-5.07-3.430.071.28
Capital Expenditures---3.73-6.56-1.27-1.04-0.98-0.18-0.45
Net Assets From Acquisitions---0.140.00-1.13-3.42-0.93-0.03-0.55
Sale of Fixed Assets and Businesses--6.004.166.783.910.030.050.00
Purchase or Sale of Investments--0.16-0.020.00-0.660.34-0.42-0.07
Purchase of Investments---0.04-0.020.00-0.72-0.25-0.47-0.81
Sale Or Maturity of Investments--0.200.000.000.050.590.060.74
Other Uses--0.000.000.000.000.000.000.00
Other Sources--0.100.080.020.440.230.230.35
Cash from Investing Activities--2.39-2.344.41-0.76-1.31-0.35-0.72
Cash Dividends Paid--0.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)--0.000.000.000.000.000.000.00
Change in Capital Stock--5.731.140.00-1.5810.096.020.00
Repurchase of Common Pref Stock--0.000.000.000.000.000.000.00
Sale of Common Pref Stock--5.731.140.00-1.5810.096.020.00
Proceedsfrom Stock Options--5.731.140.00-1.5810.036.020.00
Issuance or Reduction of Debt, Net--2.152.142.59-2.293.64-2.22-0.67
Change in Long Term Debt--1.34-0.703.82-2.295.33-2.22-2.30
Issuance of Long Term Debt--1.980.004.160.007.260.000.81
Reduction of Long Term Debt---0.64-0.70-0.34-2.29-1.93-2.22-3.12
Net Financing Active Other Cash Flow--0.000.000.00-0.03-0.32-0.760.00
Other Financing Activities Uses--0.000.000.00-0.03-0.32-0.760.00
Cash from Financing Activities--7.883.282.59-3.8913.413.05-0.67
Net Change in Cash--1.47-3.551.79-9.738.672.77-0.11
Free Cash Flow---9.26-5.46-6.13-5.94-4.120.000.97

Balance sheet, quarterly

Currency USD, millions
Metric2024S22024S12023S22023S12022S2
Cash & Short Term Investments-2.140.940.940.994.79
Short Term Receivables-12.743.818.716.6910.04
Inventories-0.961.000.991.340.86
Other Current Assets-1.381.141.831.792.22
Total Current Assets-17.226.8812.4710.8117.91
Net Property, Plant & Equipment-15.9714.7118.0217.5018.04
Total Investments and Advances-0.560.510.580.370.40
Intangible Assets-9.737.799.976.637.15
Deferred Tax Assets-7.220.637.13-0.01
Other Assets-5.665.116.145.936.89
Total Assets-56.8836.2254.9941.9251.14
Short Term Debt Incl. Current Port. of LT Debt-12.128.298.965.816.59
Accounts Payable-6.450.770.981.451.57
Income Tax Payable-0.370.030.110.170.45
Other Current Liabilities-7.6611.4215.2115.2018.99
Total Current Liabilities-26.6120.5225.2622.6327.60
Long Term Debt-13.0513.8916.9216.8217.90
Deferred Tax Liabilities-5.40-6.41-0.01
Other Liabilities-1.851.922.433.033.72
Total Liabilities-49.3238.4953.4644.7951.59
Non-Equity Reserves-0.000.000.000.000.00
Preferred Stock - Carrying Value-1.270.000.000.000.00
Common Equity-5.94-2.261.50-2.87-0.45
Total Shareholders Equity-7.21-2.261.50-2.87-0.45
Accumulated Minority Interest-0.35-0.010.040.000.00
Total Equity-7.56-2.261.53-2.87-0.45
Total Liabilities & Stockholders Equity-56.8836.2254.9941.9251.14
Book Value Per Share-0.75-0.460.31-0.59-0.09
Tangible Book Value Per Share--0.48-2.04-1.74-1.94-1.56
Price to Book Ratio--2.2512.80-62.06-58.91-7.67
Return on Assets-1.83-1.551.11-0.651.65
Return on Equity-23.48-112.33--
Return on Invested Capital-23.92-32.8817.47-18.8613.54
Quick Ratio-0.610.290.450.420.62
Current Ratio-0.650.340.490.480.65

Cash flow, quarterly

Currency USD, millions
Metric2024S22024S12023S22023S12022S2
Net Income-4.78-3.873.42-2.632.54
Depreciation-0.641.290.980.750.58
Other Funds (Non Cash)--7.91-2.52-6.14-2.18-3.57
Funds from Operations--3.75-5.10-2.44-4.06-0.45
Extraordinary Item-0.000.000.000.000.00
Changes in Working Capital-0.08-0.062.64-0.46-2.13
Income Taxes Payable-0.36-0.07-0.05-0.260.09
Cash from Operating Activities--3.67-5.160.20-4.52-2.58
Capital Expenditures--2.58-1.16-5.27-1.04-0.60
Net Assets From Acquisitions--0.140.000.000.000.14
Sale of Fixed Assets and Businesses--0.016.031.662.343.86
Purchase or Sale of Investments-0.020.13-0.020.000.11
Purchase of Investments--0.00-0.04-0.020.000.11
Sale Or Maturity of Investments-0.030.170.000.000.00
Other Uses-0.000.000.000.000.00
Other Sources-0.090.010.080.000.01
Cash from Investing Activities--2.625.01-3.551.303.52
Cash Dividends Paid-0.000.000.000.000.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.00
Change in Capital Stock-5.710.051.100.000.00
Repurchase of Common Pref Stock-0.000.000.000.000.00
Sale of Common Pref Stock-5.710.051.100.000.00
Proceedsfrom Stock Options-5.710.051.100.000.00
Issuance or Reduction of Debt, Net-1.810.352.45-0.402.93
Change in Long Term Debt-1.66-0.31-0.28-0.404.49
Issuance of Long Term Debt-1.990.000.000.003.92
Reduction of Long Term Debt--0.33-0.31-0.28-0.400.58
Net Financing Active Other Cash Flow-0.000.000.000.000.00
Other Financing Activities Uses-0.000.000.000.000.00
Cash from Financing Activities-7.510.403.55-0.402.93
Net Change in Cash-1.230.250.20-3.613.87
Free Cash Flow--4.02-5.28-0.31-4.94-3.11

Revenue breakdown

Directly-operated salons2024: 48.55M
Franchise2024: 5.23M
Other revenues2024: 1.01M
Japan2024: 54.80M
Digital Preventative Healthcare2024: 1.01M
Luxury Beauty2024: 4.62M
Relaxation Salon2024: 49.17M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-30-0.0M-144.64K
2026-10-15-0.0M-134.75K
2026-09-30-0.0M-25.59K
2026-09-15-0.0M-41.90K
2026-08-31-0.0M-52.28K
2026-08-14-0.0M-373.95K
2026-07-31-0.0M-367.85K
2026-07-15-0.1M-376.22K
2026-06-30-0.1M-372.74K
2026-06-15-0.1M-352.27K
2026-05-29-0.3M-359.51K
2026-05-15-0.1M-306.17K
2026-04-30-0.1M-311.62K
2026-04-15-0.1M-363.37K
2026-03-31-0.1M-371.33K
2026-03-13-0.1M-387.69K
2026-02-27-0.0M-391.56K
2026-02-13-0.0M-122.10K
2026-01-30-0.1M-133.57K
2026-01-15-0.1M-226.48K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-14SEC
2026-08-28SCHEDULE 13D/ASEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-27SEC
2026-08-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-28SEC
2026-08-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-28SEC
2026-08-076-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-07SEC
2026-08-076-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-07SEC
2026-07-17SCHEDULE 13D/ASEC
2026-06-256-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-26SEC
2026-06-093Initial statement of beneficial ownership of securities2026-05-29SEC
2026-05-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-29SEC
2026-05-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-28SEC
2026-04-30NT 20-F2025-12-31SEC
2026-04-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-22SEC
2026-04-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-08SEC
2026-03-30SCHEDULE 13D/ASEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-02-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-02-26SEC
2026-02-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-02-03SEC
2026-02-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-30SEC
2026-01-236-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-23SEC
2026-01-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-08SEC
2025-12-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-29SEC
2025-12-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-22SEC
2025-12-156-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-15SEC
2025-12-126-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-11SEC
2025-12-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-04SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
CITADEL ADVISORS LLC0.71%
HRT FINANCIAL LP0.69%
UBS Group AG0.36%
Virtu Financial LLC0.20%
Ground Swell Capital, LLC0.19%
TWO SIGMA SECURITIES, LLC0.13%
RHUMBLINE ADVISERS0.04%
Arax Advisory Partners0.00%
GAMMA Investing LLC0.00%

Funds

Fund% owned
-

OakChart. MRM. Cached 15 minutes.

Some panels did not load: ratings, insider.